£203.36

It has never been this cheap. We have no record of a lower price.

£203 today · cheaper than every other day in the last 3 months

Springer Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 1074 (Advances in Experimental Medicine and Biology, 1074)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 68 days · 68 data points (no recent data)

Historical
Generating forecast…
£203.46 £203.35 £203.37 £203.40 £203.42 £203.45 £203.47 25 July 2026 10 August 2026 27 August 2026 13 September 2026 30 September 2026
View at Amazon ↗

Price data last checked 23 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 68 days • 1 price levels

Days at Price
68 days 0 17 34 51 68 £203 Days at Price

Price Analysis

Most common price: £203 (68 days, 100.0%)

Price range: £203 - £203

Price levels: 1 different prices over 68 days

Description

The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium will focus on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the “best” and “most important” meetings in the field. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2014. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2018 meeting and included in the proposed volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
14 February 2019
Listed Since
13 February 2019

Barcode

No barcode data available

Similar Products You Might Like

Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 1185 (Advances in Experimental Medicine and Biology, 1185)
99% match

Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 1185 (Advances in Experimental Medicine and Biology, 1185)

Springer

£233.25 21 Aug 2026
Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 1185 (Advances in Experimental Medicine and Biology, 1185)
99% match

Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 1185 (Advances in Experimental Medicine and Biology, 1185)

Springer

£227.29 23 Aug 2026
Studies on Retinal and Choroidal Disorders: Oxidative Stress in Applied Basic Research and Clinical Practice
97% match

Studies on Retinal and Choroidal Disorders: Oxidative Stress in Applied Basic Research and Clinical Practice

Humana

£78.00 26 Sep 2026
The Retina Illustrated
97% match

The Retina Illustrated

Thieme

£86.88 28 Aug 2026
Macular Dystrophies
97% match

Macular Dystrophies

Springer

£88.19 03 Sep 2026
Retinal Degenerative Diseases XIX: Mechanisms and Experimental Therapy: 1415 (Advances in Experimental Medicine and Biology, 1415)
97% match

Retinal Degenerative Diseases XIX: Mechanisms and Experimental Therapy: 1415 (Advances in Experimental Medicine and Biology, 1415)

Springer

£277.72 06 Aug 2026
Animal Models for Retinal Diseases: 46 (Neuromethods, 46)
97% match

Animal Models for Retinal Diseases: 46 (Neuromethods, 46)

Humana

£103.27 17 Sep 2026
Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 801 (Advances in Experimental Medicine and Biology)
97% match

Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 801 (Advances in Experimental Medicine and Biology)

Springer

£203.36 25 Aug 2026
Studies on Retinal and Choroidal Disorders - Oxidative Stress
97% match

Studies on Retinal and Choroidal Disorders - Oxidative Stress

Humana

£141.67 13 Oct 2026
Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 801 (Advances in Experimental Medicine and Biology, 801)
97% match

Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 801 (Advances in Experimental Medicine and Biology, 801)

Springer

£139.00 25 Aug 2026
Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 1074 (Advances in Experimental Medicine and Biology, 1074)
97% match

Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 1074 (Advances in Experimental Medicine and Biology, 1074)

Springer

£203.36 25 Aug 2026
Retinal Degenerative Diseases: Laboratory and Therapeutic Investigations: 664 (Advances in Experimental Medicine and Biology, 664)
96% match

Retinal Degenerative Diseases: Laboratory and Therapeutic Investigations: 664 (Advances in Experimental Medicine and Biology, 664)

Springer

£203.36 19 Aug 2026
Recent Advances In Retinal Degeneration: 613 (Advances in Experimental Medicine and Biology, 613)
96% match

Recent Advances In Retinal Degeneration: 613 (Advances in Experimental Medicine and Biology, 613)

Springer

£147.14 24 Sep 2026
Retinal Degenerations: Mechanisms and Experimental Therapy: 533 (Advances in Experimental Medicine and Biology, 533)
96% match

Retinal Degenerations: Mechanisms and Experimental Therapy: 533 (Advances in Experimental Medicine and Biology, 533)

Springer

£148.27 21 Aug 2026
Age-related Macular Degeneration: Clinic to Genes - Springer
96% match

Age-related Macular Degeneration: Clinic to Genes - Springer

Springer

£120.83 06 Oct 2026
Retinal Gene Therapy: Methods and Protocols: 1715 (Methods in Molecular Biology, 1715)
96% match

Retinal Gene Therapy: Methods and Protocols: 1715 (Methods in Molecular Biology, 1715)

Humana

£54.58 10 Oct 2026
Macular Disorders Retina Atlas - Springer Medical Reference
96% match

Macular Disorders Retina Atlas - Springer Medical Reference

Springer

£114.66 03 Oct 2026
2021-2022 Basic and Clinical Science Course, Section 12: Retina and Vitreous
96% match

2021-2022 Basic and Clinical Science Course, Section 12: Retina and Vitreous

American Academy of Ophthalmology

£170.00 05 Sep 2026
Retinal Degenerative Diseases: Mechanisms and Experimental Therapy
96% match

Retinal Degenerative Diseases: Mechanisms and Experimental Therapy

Springer

£139.01 22 Oct 2026
New Insights Into Retinal Degenerative Diseases
96% match

New Insights Into Retinal Degenerative Diseases

Springer

£77.28 23 Sep 2026
Clinical Cases in Medical Retina: A Diagnostic Approach
96% match

Clinical Cases in Medical Retina: A Diagnostic Approach

Elsevier

£73.84 27 Aug 2026
Age-Related Macular Degeneration: Prevalence, Risk Factors & Clinical Management (Eye and Vision Research Developments)
96% match

Age-Related Macular Degeneration: Prevalence, Risk Factors & Clinical Management (Eye and Vision Research Developments)

£104.00 13 Aug 2026
Controversies in Neuro-Ophthalmic Management: An Evidence and Case-Based Appraisal
96% match

Controversies in Neuro-Ophthalmic Management: An Evidence and Case-Based Appraisal

Springer

£106.78 23 Sep 2026
Age-Related Macular Degeneration: Current Management
96% match

Age-Related Macular Degeneration: Current Management

Slack

£107.39 24 Sep 2026